14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $11.81 $14.31 Friday, 3rd May 2024 TRDA stock ended at $13.16. This is 2.95% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 7.14% from a day low at $12.92 to a day high of $13.84.
90 days $11.35 $15.57
52 weeks $10.74 $18.44

Historical Entrada Therapeutics, Inc. prices

Date Open High Low Close Volume
May 03, 2024 $13.70 $13.84 $12.92 $13.16 36 037
May 02, 2024 $13.25 $13.59 $12.72 $13.56 67 224
May 01, 2024 $11.98 $13.35 $11.98 $13.25 98 457
Apr 30, 2024 $12.29 $12.29 $11.82 $11.85 50 223
Apr 29, 2024 $12.36 $12.55 $12.11 $12.34 50 744
Apr 26, 2024 $12.49 $12.73 $12.39 $12.45 24 519
Apr 25, 2024 $12.23 $12.58 $11.91 $12.36 78 637
Apr 24, 2024 $12.79 $12.79 $12.31 $12.43 34 905
Apr 23, 2024 $13.22 $14.03 $12.83 $12.89 42 822
Apr 22, 2024 $12.24 $13.13 $12.20 $13.10 98 699
Apr 19, 2024 $11.83 $12.19 $11.81 $12.15 85 485
Apr 18, 2024 $12.12 $12.40 $11.83 $11.91 122 113
Apr 17, 2024 $12.71 $12.89 $12.16 $12.22 55 732
Apr 16, 2024 $12.87 $13.01 $12.60 $12.72 48 949
Apr 15, 2024 $13.03 $13.54 $12.79 $12.89 57 262
Apr 12, 2024 $13.18 $13.51 $12.76 $12.95 54 258
Apr 11, 2024 $12.75 $13.26 $12.59 $13.26 72 264
Apr 10, 2024 $12.92 $13.32 $12.24 $12.52 112 348
Apr 09, 2024 $13.58 $13.66 $13.01 $13.28 67 580
Apr 08, 2024 $13.81 $14.13 $13.40 $13.45 55 527
Apr 05, 2024 $13.83 $14.06 $13.53 $13.81 102 037
Apr 04, 2024 $14.08 $14.31 $13.68 $13.83 48 877
Apr 03, 2024 $13.62 $14.22 $13.62 $13.81 53 067
Apr 02, 2024 $13.60 $13.96 $13.17 $13.88 63 076
Apr 01, 2024 $14.38 $14.38 $13.41 $13.76 53 080
Click to get the best stock tips daily for free!

About Entrada Therapeutics, Inc.

Entrada Therapeutics. Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in preclinical trail for the treatment of Duchenne muscular dystrophy and myotonic dystrophy type 1. It also eng... TRDA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT